tradingkey.logo
tradingkey.logo
検索

Enovis Corp

ENOV
ウォッチリストに追加
22.515USD
+2.475+12.35%
終値 07/02, 13:00ET15分遅れの株価
1.30B時価総額
損失額直近12ヶ月PER

詳細情報 Enovis Corp 企業名

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corpの企業情報

企業コードENOV
会社名Enovis Corp
上場日May 08, 2008
最高経営責任者「CEO」Mcdonald (Damien)
従業員数7367
証券種類Ordinary Share
決算期末May 08
本社所在地2711 Centerville Road
都市WILMINGTON
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号19808
電話番号13022529160
ウェブサイトhttps://www.enovis.com/
企業コードENOV
上場日May 08, 2008
最高経営責任者「CEO」Mcdonald (Damien)

Enovis Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
17.60K
+53.09%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%

よくある質問

Enovis Corpの上位5名の株主は誰ですか?

Enovis Corpの上位5名の株主は以下のとおりです。Mr. Daniel Alexis Pryor

Enovis Corp(ENOV)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Enovis Corpの株式を保有している機関は652社あり、保有株式の総市場価値は約68.97Mで、全体の119.81%を占めています。2025Q4と比較して、機関の持ち株は-6763998.00増加しています。

Enovis Corpの最大の収益源は何ですか?

2026Q1において、Medical Technology-Prevention & Rehabilitation部門がEnovis Corpにとって最大の収益を生み出しており、その金額は1.14Bで、全収益の50.58%を占めています。